Chief Technology Officer
HeartBeat.Bio
Vienna, Austria
Trained as a chemist, Florian Fuchs quickly got interested in biological models and assay evaluations. Having received his PhD from the Ludwig-Maximilians-University at Munich and educated himself on Genome-wide siRNA perturbations and implementation of High Content Screening at the German Cancer Research Center at Heidelberg, he joined the Novartis Biomedical Research Institutes at Novartis Basel in 2010. There, he started as a lab head in cell-based assays and was holding a group leader position on cell-based screening and advanced cellular models. In 2021 he moved to Berlin to work as a lab head within the Lead Discovery Screening Department of the Nuvisan Innovation Campus Berlin. Since February 2022, he was appointed Chief Technology Officer (CTO) at HeartBeat.bio AG (HBB) at Vienna .
Disclosure information not submitted.